Park JH - Search Results

1

The Role of Hippo Pathway in Cancer Stem Cell Biology.

Park JH, Shin JE, Park HW. Park JH, et al. Among authors: park hw. Mol Cells. 2018 Feb 28;41(2):83-92. doi: 10.14348/molcells.2018.2242. Epub 2018 Feb 5. Mol Cells. 2018. PMID: 29429151 Free PMC article. Review.

2

Hypersensitivity to DNA double-strand breaks associated with PARG deficiency is suppressed by exo-1 and polq-1 mutations in Caenorhabditis elegans.

Bae W, Park JH, Lee MH, Park HW, Koo HS. Bae W, et al. Among authors: park hw, park jh. FEBS J. 2020 Mar;287(6):1101-1115. doi: 10.1111/febs.15082. Epub 2019 Oct 21. FEBS J. 2020. PMID: 31593615 Free article.

3

O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity.

Kim E, Kang JG, Kang MJ, Park JH, Kim YJ, Kweon TH, Lee HW, Jho EH, Lee YH, Kim SI, Yi EC, Park HW, Yang WH, Cho JW. Kim E, et al. Among authors: park hw, park jh. Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14259-14269. doi: 10.1073/pnas.1913469117. Epub 2020 Jun 8. Proc Natl Acad Sci U S A. 2020. PMID: 32513743 Free PMC article.

4

Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets.

Park JH, Pyun WY, Park HW. Park JH, et al. Among authors: park hw. Cells. 2020 Oct 16;9(10):2308. doi: 10.3390/cells9102308. Cells. 2020. PMID: 33081387 Free PMC article. Review.

5

Hot Spot Analysis of YAP-TEAD Protein-Protein Interaction Using the Fragment Molecular Orbital Method and Its Application for Inhibitor Discovery.

Kim J, Lim H, Moon S, Cho SY, Kim M, Park JH, Park HW, No KT. Kim J, et al. Among authors: park hw, park jh. Cancers (Basel). 2021 Aug 23;13(16):4246. doi: 10.3390/cancers13164246. Cancers (Basel). 2021. PMID: 34439400 Free PMC article.

6

The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1α accumulation.

Kim I, Kim M, Park MK, Naik R, Park JH, Kim BK, Choi Y, Chang KY, Won M, Ban HS, Lee K. Kim I, et al. Among authors: park mk, park jh. Exp Mol Med. 2020 Nov;52(11):1845-1856. doi: 10.1038/s12276-020-00523-5. Epub 2020 Nov 25. Exp Mol Med. 2020. PMID: 33235318 Free PMC article.

7

Dual-targeting RNA nanoparticles for efficient delivery of polymeric siRNA to cancer cells.

Kim T, Hyun HN, Heo R, Nam K, Yang K, Kim YM, Lee YS, An JY, Park JH, Choi KY, Roh YH. Kim T, et al. Among authors: park jh. Chem Commun (Camb). 2020 Jun 18;56(49):6624-6627. doi: 10.1039/d0cc01848a. Chem Commun (Camb). 2020. PMID: 32463029

8

Extracellular vesicles from adipose tissue-derived stem cells alleviate osteoporosis through osteoprotegerin and miR-21-5p.

Lee KS, Lee J, Kim HK, Yeom SH, Woo CH, Jung YJ, Yun YE, Park SY, Han J, Kim E, Sul JH, Jung JM, Park JH, Choi JS, Cho YW, Jo DG. Lee KS, et al. Among authors: park jh, park sy. J Extracell Vesicles. 2021 Oct;10(12):e12152. doi: 10.1002/jev2.12152. J Extracell Vesicles. 2021. PMID: 34596354 Free PMC article.

9

Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism.

Naik R, Ban HS, Jang K, Kim I, Xu X, Harmalkar D, Shin SA, Kim M, Kim BK, Park J, Ku B, Oh S, Won M, Lee K. Naik R, et al. J Med Chem. 2017 Oct 26;60(20):8631-8646. doi: 10.1021/acs.jmedchem.7b01231. Epub 2017 Oct 16. J Med Chem. 2017. PMID: 28991459

10

Simultaneous Delivery of Electrostatically Complexed Multiple Gene-Targeting siRNAs and an Anticancer Drug for Synergistically Enhanced Treatment of Prostate Cancer.

Choi E, Yoo W, Park JH, Kim S. Choi E, et al. Among authors: park jh. Mol Pharm. 2018 Sep 4;15(9):3777-3785. doi: 10.1021/acs.molpharmaceut.8b00227. Epub 2018 Aug 2. Mol Pharm. 2018. PMID: 30028622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,819 results

Search Page